Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on carbonylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel CuCl catalyzed method for 1,2,4-triazolyl arylamines offers scalable production and cost reduction in pharmaceutical intermediates manufacturing without anhydrous conditions.
Novel Pd-catalyzed carbonylation method for indole-3-carboxamide. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN112694430B details a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrol-2-one intermediates, offering safer CO surrogates and high yields for API manufacturing.
Patent CN112694430B details a novel Pd-catalyzed bis-carbonylation route for pyrrol-2-one scaffolds, offering safer conditions and high yields for API intermediates.
Patent CN119823040A reveals efficient Pd-catalyzed synthesis. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method for 2-CF3 imidazoles offers high yield and scalability for reliable pharmaceutical intermediate suppliers.
Novel nickel-catalyzed method using nitroarenes and molybdenum carbonyl ensures safe scalable production of high-purity pharmaceutical intermediates with reduced operational complexity.
Novel carbonylation cyclization method for N-acyl indoles offers high yield and substrate tolerance, optimizing API intermediate manufacturing costs.
Novel Pd-catalyzed carbonylation method for high-purity imidazoles. Reduces cost and improves supply chain reliability for pharma manufacturing.
Patent CN111423381B reveals a mild Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering reliable pharmaceutical intermediate supply with enhanced cost efficiency.
Novel nickel-catalyzed method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing without toxic carbon monoxide gas usage globally.
Patent CN111423381B details a novel Pd-catalyzed carbonylation route for 2-trifluoromethyl imidazoles, offering high efficiency and cost-effective manufacturing for pharma intermediates.
Patent CN112239456B details a novel Pd-catalyzed carbonylation for 2,3-dihydroquinolones. This method offers high efficiency, broad substrate scope, and significant cost reduction in API manufacturing.
Novel palladium-catalyzed method offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Novel nickel-catalyzed carbonylation method for indoles. High efficiency, broad substrate scope, cost-effective for pharma intermediates manufacturing.
Novel Pd-catalyzed carbonylation route for quinolinones using benzisoxazole. High yield, broad scope, cost-effective for API intermediates.
Novel palladium-catalyzed carbonylation method for indole and benzoxazine compounds. Offers scalable manufacturing and cost reduction for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for quinazolinones using solid CO source. Safe, high-yield, scalable process for API intermediates and fine chemicals.
Patent CN113735826B reveals efficient Pd-catalyzed carbonylation route. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Novel palladium-catalyzed carbonylation cyclization for high-purity thiochromene derivatives. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing partners globally.